HomeUTHR • NASDAQ
add
United Therapeutics Corp
Previous close
$284.82
Day range
$281.51 - $288.54
Year range
$232.94 - $417.82
Market cap
12.90B USD
Avg Volume
511.17K
P/E ratio
11.65
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 735.90M | 19.72% |
Operating expense | 298.10M | 5.52% |
Net income | 301.30M | 38.78% |
Net profit margin | 40.94 | 15.91% |
Earnings per share | 6.19 | 41.97% |
EBITDA | 381.60M | 38.81% |
Effective tax rate | 24.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.27B | 9.11% |
Total assets | 7.36B | 2.75% |
Total liabilities | 920.00M | -22.18% |
Total equity | 6.44B | — |
Shares outstanding | 44.91M | — |
Price to book | 1.98 | — |
Return on assets | 12.49% | — |
Return on capital | 13.62% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 301.30M | 38.78% |
Cash from operations | 341.20M | 126.41% |
Cash from investing | -123.20M | -392.64% |
Cash from financing | -74.70M | 19.50% |
Net change in cash | 143.30M | 43.30% |
Free cash flow | 206.85M | 124.32% |
About
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,305
